
Journal of Medicinal Chemistry p. 1404 - 1408 (1981)
Update date:2022-08-05
Topics:
Brandt, Joan A.
Ludeman, Susan Marie
Zon, Gerald
Todhunter, John A.
Egan, William
Dickerson, Ruth
Hydrogenolysis of 3-(benzyloxy)cyclophosphamide (10) using Pd/C catalyst and ethyl acetate as solvent leads to the formation of 3-hydroxycyclophosphamide (3, ca. 20percent) and cyclophosphamide (1, ca. 10percent), accompanied by regioselective hydrogen-exchange reactions at the C-4 and C-5 positions in 3 and 1.A variety of oxidizing reagents and liver microsomal incubation failed to provide evidence (31P NMR) for conversion of 1 into 3, whereas identical incubation of 3 led to its reduction to 1.Compound 3 is stable at pH 6.5-8.2, 37 deg C, and exhibits anticancer activity comparable to 1 when tested against L1210 leukemia in mice.Data are discussed with regard to a previously reported suggestion that metabolism of 1 may involve oxidation to give 3 followed by rearrangement of 3 to 2.
View MoreArshine Pharmaceutical Co., Limited
website:http://www.cnarshine.com
Contact:0731-88503671
Address:Room 1109.Block C3, Lugu Enterprise Plaza,No.27 Wenxuan Road,Changsha National Hi-Tech Industrial Development Zone,Hunan ,P.R.China
Shanghai He Yang International Trading Co., Ltd.
Contact:+86-21-52043598
Address:Room 816, Blag.5, No.58 Huachi Road
Daqing E-shine Chemical Co.,LTD
Contact:0086-024-31285112
Address:Hongweiyuan area, Ranghulu district
ShangHai Soyoung Biotechnology Inc
website:http://www.soyoungbio.com
Contact:+86-21-69893009
Address:shanghai
Hubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
Doi:10.1021/ja01369a055
(1930)Doi:10.1016/S0040-4039(01)81393-9
(1984)Doi:10.1055/s-1981-29368
(1981)Doi:10.1002/anie.200460791
(2004)Doi:10.1016/j.tetlet.2004.08.021
(2004)Doi:10.1007/BF00955267
()